TD Waterhouse Canada’s BeOne Medicines Ltd ONC Stock Holding History

TD Waterhouse Canada’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$573K	Sell	1,975 -57	-3%	-$16.8K	﹤0.01%	843
2026 Q1	$626K	Buy	+2,032	New	+$658K	﹤0.01%	791
2025 Q4	–	Sell	-9	Closed	-$3.02K	–	2193
2025 Q3	$3.02K	Buy	+9	New	+$2.73K	﹤0.01%	1772
2024 Q3	–	Sell	-5	Closed	-$724	–	2038
2024 Q2	$724	Buy	+5	New	+$771	﹤0.01%	1751
2023 Q2	–	Sell	-22	Closed	-$4.68K	–	1835
2023 Q1	$4.68K	Buy	+22	New	+$5.28K	﹤0.01%	1383
2022 Q4	–	Sell	-8	Closed	-$1.25K	–	1790
2022 Q3	$1.25K	Hold	8	–	–	﹤0.01%	1556
2022 Q2	$1.48K	Buy	8 +3	+60%	+$469	﹤0.01%	1577
2022 Q1	$984	Buy	5 +3	+150%	+$638	﹤0.01%	1673
2021 Q4	$492	Buy	+2	New	+$675	﹤0.01%	1684

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TD Waterhouse Canada's ONC Position: Q2 2026 in Review

TD Waterhouse Canada reduced its BeOne Medicines Ltd (ONC) stake by 2.8% in Q2 2026, selling an estimated $16.8K and leaving 1,975 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

TD Waterhouse Canada first reported a position in ONC in Q4 2021 and has held it in 9 quarters since. The position peaked at $626K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

TD Waterhouse Canada held 1,975 shares of BeOne Medicines Ltd worth $573K as of Q2 2026.
TD Waterhouse Canada sold 57 BeOne Medicines Ltd shares in Q2 2026, an estimated $16.8K.
BeOne Medicines Ltd made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #843 holding.
TD Waterhouse Canada first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 9 quarters since.
TD Waterhouse Canada's BeOne Medicines Ltd position peaked at $626K in Q1 2026.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.